Boost Your Productivity!Translate documents (Ms-Word, Ms-Excel, ...) faster and better thanks to artificial intelligence!
https://pro.wordscope.com
https://blog. wordscope .com
Amministrazione per l'alimentazione e i medicinali
Date rape drug
FDA
Farmaco orfano
Food and drug administration
Gocce KO
Liquid ecstasy
Medicamento importante per malattie rare
Medicamento orfano
Medicinale orfano
Organismo di controllo degli alimenti e dei farmaci
Orphan drug
Smart drug
Trattamento drug-free
Trattamento in drug-free

Vertaling van "orphan drug " (Italiaans → Engels) :

TERMINOLOGIE
medicamento orfano | medicamento importante per malattie rare | orphan drug | medicinale orfano | farmaco orfano

orphan medicinal product | orphan medicine | orphan drug


trattamento drug-free | trattamento in drug-free

drug-free treatment


Agenzia per gli alimenti e i medicinali degli Stati Uniti | Amministrazione per l'alimentazione e i medicinali | food and drug administration | Organismo di controllo degli alimenti e dei farmaci | FDA [Abbr.]

Food and Drug Administration | United States Food and Drug Administration | US Food and Drug Administration | FDA [Abbr.] | US FDA [Abbr.]




gocce KO (1) | liquid ecstasy (2) | date rape drug (3)

date rape drug (1) | liquid ecstasy (2)
IN-CONTEXT TRANSLATIONS
[16] Gli argomenti inerenti le malattie rare negli inviti a presentare proposte in ambito sanitario del 7° PQ del 2012 e del 2013 sono stati i seguenti: Support for international rare disease research; Clinical utility of –omics for better diagnosis of rare diseases; Databases, biobanks and clinical "bio-informatics" hub for rare diseases; Preclinical and clinical development of orphan drugs; Observational trials in rare diseases; Best practice and knowledge sharing in clinical management of rare diseases (2012) e Development of imaging technologies for therapeutic interventions in rare diseases; New methodologies for clinical tria ...[+++]

[16] The rare disease topics in the 2012 and 2013 FP7 Health Calls were: 'Support for international rare disease research; Clinical utility of –omics for better diagnosis of rare diseases; Databases, biobanks and clinical ‘bio-informatics’ hub for rare diseases; Preclinical and clinical development of orphan drugs; Observational trials in rare diseases; Best practice and knowledge sharing in clinical management of rare diseases (2012) and Development of imaging technologies for therapeutic interventions in rare diseases; New methodologies for clinical trials for small population groups (2013).


[16] Gli argomenti inerenti le malattie rare negli inviti a presentare proposte in ambito sanitario del 7° PQ del 2012 e del 2013 sono stati i seguenti: Support for international rare disease research; Clinical utility of –omics for better diagnosis of rare diseases; Databases, biobanks and clinical "bio-informatics" hub for rare diseases; Preclinical and clinical development of orphan drugs; Observational trials in rare diseases; Best practice and knowledge sharing in clinical management of rare diseases (2012) e Development of imaging technologies for therapeutic interventions in rare diseases; New methodologies for clinical tria ...[+++]

[16] The rare disease topics in the 2012 and 2013 FP7 Health Calls were: 'Support for international rare disease research; Clinical utility of –omics for better diagnosis of rare diseases; Databases, biobanks and clinical ‘bio-informatics’ hub for rare diseases; Preclinical and clinical development of orphan drugs; Observational trials in rare diseases; Best practice and knowledge sharing in clinical management of rare diseases (2012) and Development of imaging technologies for therapeutic interventions in rare diseases; New methodologies for clinical trials for small population groups (2013).


Programmi per fornire incentivi di RS per malattie trascurate, analoghe all'impostazione "Orphan drugs" sono raccomandati da parte di molte organizzazioni (cfr. ad esempio: MSF working papers "Drugs for Neglected Diseases Working Group").

Programmes to provide incentives to R D for neglected diseases, analagous to the Orphan drugs approach are recommended by many organisations (see for instance: MSF working papers 'Drugs for Neglected Diseases Working Group).




datacenter (19): www.wordscope.nl (v4.0.br)

'orphan drug' ->

Date index: 2022-02-15
w